Stay updated on Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record now reflects that recruitment has ceased, indicating no further participant enrollment. The history also shows a revision update to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.2%

- Check21 days agoChange DetectedA new revision entry v3.5.5 was added to the study history, and the prior revision v3.5.4 was removed from the visible changes.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision label was updated to v3.5.4 (from v3.5.3), indicating a backend/software version bump. This change reflects a site update rather than content modifications to the study record history.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s displayed software/version identifier was updated from **v3.5.2** to **v3.5.3**, reflecting a site or interface revision rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check70 days agoChange DetectedNew version entry on 2026-04-13 with Revision: v3.5.2, adding updates to Contacts/Locations and Study Status.SummaryDifference0.3%

- Check99 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

Stay in the know with updates to Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.